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NEUROVASCULAR CHANGES IN THE OA JOINT
D.A. Walsh. Univ. of Nottingham, Nottingham, United Kingdom
Purpose: To describe current knowledge leading to a better under-
standing of OA pain and potential therapeutic targets for symptom and
structural modiﬁcation.
Methods: Narrative review.
Results: Pain originates from the OA joint, mediated by primary noci-
ceptive neurons that have been localised to the majority of articular
structures. Fine, myelinated Ad ﬁbres are localised to joint capsule,
periosteum and muscles, whereas unmyelinated C ﬁbres are most
abundant with synovium and subchondral bone marrow spaces.
Unmyelinated afferents predominantly accompany blood vessels, and
serve both sensory (pain) and efferent (control of vascular tone, per-
meability and proliferation) functions. During OA, sensory nerves
change in their distribution, growing with blood vessels into articular
cartilage and the inner two thirds of knee menisci. Furthermore,
peripheral sensory nerve function is augmented (peripheral sensitisa-
tion), accompanied by changes in ion channel phosphorylation, neu-
romodulator and neurotransmitter expression. Key drivers of
peripheral sensitisation offer potential as novel therapeutic targets for
OA pain, including nerve growth factor, calcitonin gene-related peptide,
and pro-inﬂammatory cytokines. Neuronal and vascular functions are
tightly integrated, with factors originally recognised in pain processing
pathways also modulating vascular function, and others, such as vas-
cular endothelial growth factor, now known to also play important roles
in neuronal growth and sensitisation. The joint vasculature is key to
maintaining articular health, by facilitating metabolic homeostasis,
contributing to tissue repair and new bone formation. Inappropriate or
inadequate vascular responses might lead to relative hypoxia and
acidosis, loss of osteochondral integrity and persistent inﬂammation;
each of which can exacerbate OA pain.
Conclusions: Targeting the neurovascular plasticity that is observed in
OA joints might not only afford short term pain relief, but also modify
symptomatically relevant structural changes and therefore afford sus-
tained reductions in the burden of OA.
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ROLE OF ZN2þ IMPORT AND THE ZN2þ/ZIP8/MTF1 AXIS ON OA
J.-S. Chun. Gwangju Inst. of Sci. and Technology (GIST), Gwangju, Republic
of Korea
Osteoarthritis (OA), primarily characterized by cartilage degeneration,
is caused by an imbalance between anabolic and catabolic factors. Here,
we investigated the role of zinc (Zn2þ) homeostasis, Zn2þ transporters,
and Zn2þ-dependent transcription factors in OA pathogenesis. Among
Zn2þ transporters, the Zn2þ importer ZIP8 was speciﬁcally upregu-
lated in OA cartilage of humans andmice, resulting in increased levels of
intracellular Zn2þ in chondrocytes. ZIP8-mediated Zn2þ inﬂux upre-
gulated the expression of matrix-degrading enzymes (MMP3, MMP9,
MMP12, MMP13, and ADAMTS5) in chondrocytes. Ectopic expression of
ZIP8 in mouse cartilage tissue caused OA cartilage destruction, whereas
Zip8 knockout suppressed surgically induced OA pathogenesis, with
concomitant modulation of Zn2þ inﬂux and matrix-degrading
enzymes. Furthermore, MTF1 was identiﬁed as an essential tran-
scription factor in mediating Zn2þ/ZIP8-induced catabolic factor
expression, and genetic modulation of Mtf1 in mice altered OA patho-
genesis. We propose that the zincZIP8MTF1 axis is an essential
catabolic regulator of OA pathogenesis.
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THE CIRCADIAN CLOCK IN CARTILAGE HOMEOSTASIS
M. Dudek y, N. Gossan y, N. Yang y, D. Pathiranage y, H.-J. Im z, D. Jin y,
X. Li z, R. Boot-Handford y, Q.-J. Meng y. yUniv. of Manchester,
Manchester, United Kingdom; zRush Univ., Chicago, IL, USA
Purpose: Osteoarthritis (OA) is the most common joint disorder for
which age is a major risk factor. We have previously identiﬁed auton-
omous circadian clocks in chondrocytes that become dysregulated with
age and in an injury model of OA in mouse. More recently, we have
shown that environmental disruption of the circadian rhythm in mice
predisposes to OA-like cartilage degeneration in the knee. The objec-
tives were to characterize the circadian clock and their tissue-speciﬁc
targets in normal, aged and diseased cartilage tissues, and to providegenetic evidence and mechanistic insights linking the chondrocyte
circadian clock to cartilage pathologies.
Methods: Cartilage explants were obtained from aged and young mice
with the clock reporter PER2::luc, and real-time bioluminescence
recordings were used to characterize the properties of the clock. Time-
series microarrays and RNAseq were performed on mouse cartilage
tissues to identify rhythmic genes. Experimental OA was induced in
mice by destabilization of the medial meniscus (DMM). A Col2a1-Cre
driven conditional Bmal1 knockout mouse was made to evaluate the
role of chondrocyte clock in cartilage health and disease.
Results: Autonomous circadian clocks in mouse cartilage tissue and
human chondrocytes were identiﬁed, which can be entrained by sys-
temic factors such as body temperature rhythms. The circadian and
diurnal transcriptomes in mouse cartilage revealed a large number of
rhythmic genes involved in cartilage homeostasis and chondrocyte
survival. Several clock genes were disrupted in the early stages of car-
tilage degeneration in the DMM mouse model of OA, as well as in
human OA samples. Further, the conditional chondrocyte-Bmal1
knockout mouse model caused no developmental abnormalities in the
articular cartilage although signiﬁcant pathology became apparent in
the adult articular cartilage. RNAseq revealed global changes in gene
expression that favours a more catabolic state of the Bmal1 KO
chondrocytes.
Conclusions: These results reveal an autonomous circadian clock in
chondrocytes that is implicated in key aspects of cartilage tissue
homeostasis and chondrocyte health. We envisage a scenario where
chronic circadian disruption or misalignment (e.g. during aging) may
compromise cartilage tissue homeostasis and increase susceptibility to
joint damage or disease. Further investigations may lead to novel tar-
geting strategies for joint diseases, including timed drug administration
(chronotherapy), or the use of circadian clock-acting compounds.
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HOW CAN DISTURBANCES OF THE NERVOUS SYSTEMS TRANSLATE IN
OA PHENOTYPES?
F. Berenbaum. Univ. P&M Curie Paris 06, INSERM UMRS_938, APHP Saint-
Antoine, Paris, France
Osteoarthritis has long been considered as a joint disease inﬂuenced by
local factors only (such as overload, joint trauma or anatomical
deformities) which would trigger cartilage, subchondral bone and
synovial cells activation leading to the release of degradative mediators
eventually destroying the matrix. More recently, observational and
interventional experimental studies have shown that a systemic low-
grade inﬂammation component could play an additional role, at least in
a subgroup of OA patients suffering from metabolic diseases like obe-
sity, diabetes mellitus, lipid abnormalities or hypertension. Because of
the recent knowledge about close connections between inﬂammation,
metabolic diseases and the brain, the inﬂuence of nervous system
pathways on initiation and/or progression of OA could be considered,
too. In this lecture, these potential pathways involved in communica-
tions between OA joints and the nervous system will be presented. The
role of the circadian rhythms and of the autonomic nervous system on
the pathophysiology of OA will be particularly developed.
Such an integrative vision of the OA process is changing our paradigm
by including OA in the list of the metabolic diseases that could be
inﬂuenced by the brain. If conﬁrmed, this hypothesis could be a
breakthrough for treating OA, by seeking new targets modulating these
pathways. A cross-cutting approach of the pathophysiology of the dis-
ease is now inevitable for a step-forward in the treatment approach of
OA in the future.
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“BONY” PHENOTYPE: WORTHWHILE AS THERAPEUTIC TARGET?
J.H. Tobias. Univ. of Bristol, Sch. of Clinical Sci., Bristol, United Kingdom
Background: Epidemiological studies suggest a positive relationship
exists between bone mineral density (BMD) and incident osteoarthritis
(OA), but the relationship with OA progression is less certain. To
establish whether increased BMD is linked to a causal pathway for OA,
we examined OA phenotypes in a unique cohort of individuals with
high bone mass (HBM), in whom BMD is assumed to be elevated due to
genetically increased rates of bone formation.
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and knee joint replacement as compared with unaffected family con-
trols. On analysing hip and knee radiographs, compared to a combi-
nation of family and population based controls, HBM was associated
with an increased risk of osteophytes, but not joint space narrowing.
Although HBM cases have an increased risk of obesity, these radio-
graphic associations persisted after BMI adjustment. In further analyses
we found that BMD and osteophytes are positively associated with the
presence of radiographic enthesophytes, suggesting a more generalised
tendency towards bone formation (‘bone forming triad’). Taken
together, these ﬁndings suggest that higher BMD has a causal role in
hypertrophic forms of OA, as part of a bony phenotype characterised by
a generalised increase in bone formation. As supported by other evi-
dencewhich suggests that osteophytes directly contribute to pain in OA,
there may be a case for developing speciﬁc therapeutic strategies for
hypertrophic OA.
Targeting the bone phenotype in OA: (i) Biomechanical inputs: Since
osteophytes develop in response to disordered biomechanical inputs,
hypertrophic OA may preferentially respond to biomechanical inter-
ventions such as foot orthoses and muscle strengthening exercises.
(ii) Osteophyte growth: It may be possible to develop drug therapies
which target growth of osteophytes (which arise from the periosteum
and are produced via a process of endochondral bone formation),
without inﬂuencing bone remodelling and affecting the risk of osteo-
porosis. Such an action might explain the beneﬁcial effect of hormone
replacement therapy in OA, given oestrogen suppresses aspects of
endochondral bone formation and selectively inhibits bone formation
at the periosteal surface.
(iii) Nociceptive pathways: Inhibition of inﬂammatory mediators aris-
ing from cartilage, which are thought to contribute to the pathogenesis
of pain in OA, may be of little value in treating hypertrophic forms of the
disease. However, unlike articular cartilage, subchondral bone and
osteophytes are both innervated. Therefore, hypertrophic OA may be
helped by inhibition of neuronal nociceptive pathways, for which a
range of novel inhibitors are in development, intended to target
peripheral pain ﬁbres, spinal cord gate control at the level of the dorsal
root ganglion and/or central pain processing.
Conclusion: Further insights into the molecular processes which reg-
ulate osteophyte development and osteophytic nociception may be
helpful in guiding the development of novel treatments for OA which
act by targeting the bony phenotype.
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GENETIC LINKS BETWEEN DEVELOPMENT AND OSTEOARTHRITIS:
DIO2 GENE AND RISK FOR OSTEOARTHRITIS
I. Meulenbelt. Leiden Univ. Med. Ctr., Leiden, Netherlands
Previously, in the Genetics osteoARthritis and Progression (GARP) study
the deiodinase iodothyronine type II (D2) gene (DIO2) was identiﬁed as
an OA susceptibility gene with this ﬁnding conﬁrmed in other studies
especially, for hip OA in females. D2 is critical in maintaining the
availability of intracellular active thyroid hormone 3,3’,5-triiodothyr-
onine (T3). In the growth plate, T3 initiates the terminal differentiation
of hypertrophic chondrocytes, which is important for the subsequent
formation of long bones. Notably, in end-stage versus non-OA cartilage,
DIO2 expression was found to be highly upregulated whereas an allelic
imbalance was shown for the rs225014 SNP; the mRNAwith the OA risk
allele ‘C’was 30%more abundantly present in articular joint tissues than
the wild-type allele ‘T’. It was then shown that loss of epigenetic
silencing of DIO2 with the OA pathology resulted in a more vivid up
regulation of DIO2 particularly in carriers of this risk allele C. Given the
function of T3 in the growth plate during development, such signalling
in adult articular cartilage is likely detrimental. In this respect, further
studies showed that cartilage speciﬁc induction of DIO2 expression in
adult mice resulted in, OA characteristic, hypertrophic differentiation.
Subsequently, in a human in vitro 3D chondrogenesis model of human
bone-marrow derived mesenchymal stem cells it was shown that up-
regulation of DIO2 expression resulted in a marked reduction in the
capacity of chondrocytes to deposit ECM components, concurrent with
induction of OA-speciﬁc markers of cartilage matrix degeneration and
mineralization. In contrast, inhibition of deiodinases contributed to
prolonged ‘healthy’ cartilage homeostasis by virtue of a denser cartilage
matrix structure with signiﬁcant less cellular lacunae. In line with these
ﬁndings, it was very recent shown that DIO2 knockout mice, have
normal articular cartilage development yet, when subjected to astringent running regime, appear to be protected against cartilage
damage and had reduced severity of synovitis as compared to their wild
type littermates. Together these studies show that loss of epigenetic
control of the DIO2 gene with ongoing OA pathology affects the pro-
pensity of OA chondrocytes recuperate a growth plate morphology and
exhibit debilitating expression. Furthermore, focused functional follow-
up of OA susceptibility genes to elucidate underlying pathophysio-
logical mechanisms may contribute to a desirable translation from
genetic studies towards novel therapeutic options.
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SHOULD OA RESEARCH FOCUS ON “MICE” OR “MEN”?
C.B. Little. Raymond Purves Lab., Kolling Inst., Univ. of Sydney, St.
Leonards, Australia
Purpose: To argue that osteoarthritis (OA) research should focus on
“mice”.
Methods: Review the evidence that real and sustainable advances in
management and treatment of OA in “men” will ultimately come from
“mice”, i.e. preclinical research.
Results: The current model for the discovery, development and trans-
lation of successful therapies for OA into clinical practice has clearly not
been successful. The easy conclusion to drawwould be that what works
in “mice” is not relevant to “men”, and to set aside our preclinical
research efforts. In this presentation we will explore in more depth the
reasons for translational failure in OA, and make the case that far from
cutting preclinical research, we should increase our focus in this area.
Conclusions: Preclinical “mice” research will provide the foundation on
which rational and effective OA treatments in “men” will be based.
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SHOULD OA RESEARCH FOCUS ON “MICE” OR “MEN”?
D.J. Hunter y,z. y Inst. of Bone and Joint Res., Univ. of Sydney, St Leonards,
Australia; zRheumatology Dept., Royal North Shore Hosp., Sydney,
Australia
Purpose: To argue that osteoarthritis research should focus on “men”.
Methods: Provide supportive evidence to support the case that osteo-
arthritis research should focus on human disease. The presentation will
also respond to the arguments made that osteoarthritis research should
focus on mice.
Results: Given the burden of disease in humans and the limited source
of research funding prioritization is required. A case will be made that
too much emphasis is placed on research into mice and insufﬁcient
focus is made on human research.
Conclusions: There is insufﬁcient focus on human research into
osteoarthritis and too great an emphasis is placed on research on mice.
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OSTEOARTHRITIS: INSIGHTS INTO DISEASE INITIATION AND
PROGRESSION FROM MR IMAGING
G. Gold. Stanford Univ. Dept. of Radiology, Stanford, CA, USA
Purpose:Magnetic Resonance Imaging (MRI) has provided researchers
with an opportunity to examine joints non-invasively. Both the mor-
phology and composition of articular cartilage and other tissues can be
measured using MRI. A variety of MRI contrast mechanisms exist that
can give unique information about tissue composition. This information
can gain insight into disease initiation and progression.
Methods: Many different contrast mechanisms are useful with MRI to
examine joint morphology. In general, three-dimensional approaches
are superior for quantitative evaluation of cartilage volume and thick-
ness. Three-dimensional spoiled gradient echo (SPGR, FLASH) with dark
synovial ﬂuid have been used extensively in multiple studies. Other
methods with bright synovial ﬂuid include balanced steady state free
precession (bSSFP), dual-angle steady state (DESS) MRI, and vastly
interpolate projection reconstruction (VIPR). Three-dimensional fast-
spin-echo (3D-FSE) is a new method that may enable cartilage mor-
phology and semi-quantitative scoring of other structures with a single
acquisition. Important in all of these cartilage studies are accurate
image segmentation and registration.
For imaging tissue composition, multiple approaches have proven
useful. The collagen matrix of the cartilage and the meniscus can be
evaluatedwith T2 relaxation timemapping, magnetization transfer, and
